Zealand Pharma A/s Stock
Zealand Pharma A/s Stock
Zealand Pharma A/s gained 1.180% today.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Zealand Pharma A/s stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Zealand Pharma A/s in the next few years
Pros
?
S********** s********
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Zealand Pharma A/s vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Zealand Pharma A/s | 1.180% | -3.548% | 11.695% | -33.350% | -39.247% | 32.843% | 41.758% |
| Saniona AB | -2.060% | -8.099% | -7.480% | 136.724% | -28.415% | 98.698% | -37.306% |
| Ocuphire Pharma Inc. | -2.110% | 16.244% | 8.402% | 620.126% | 172.295% | -11.068% | - |
| Immunic Inc. | 7.500% | 4.839% | 0.971% | 31.313% | 141.860% | -24.198% | -91.275% |
News
Why 2026 Could Be Another Breakout Year for Rocket Lab
The momentum has shown little sign of slowing for Rocket Lab (NASDAQ: RKLB). Shares of the aerospace and defense company have gone from strength to strength, rising roughly 1,775% over the past
New APAC Partnership with Matter Brings Market Logic Software's Always-On Insights Solutions to Local Brand and Experience Leaders
BERLIN, DE / ACCESS Newswire / December 16, 2025 / Market Logic Software, the market-leading SaaS provider of insight management solutions, has announced a partnership with Matter, a New
